A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects
Clinical trial NCT05503693 · COMPLETED
Trial details
- NCT number
- NCT05503693
- Sponsor
- Alebund Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2023-07-21
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.